MRNA News & Events

The Dow Jones closed slightly in positive territory, while the S&P 500 and Nasdaq were sharply higher after the April jobs report beat forecasts. Chip stocks rebounded after yesterday's pause, helping lift the Nasdaq back toward record territory. Oil briefly pushed back above $100 after renewed U.S.-Iran clashes in the Strait of Hormuz, but equities have largely treated each flare-up as temporary noise.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiawillin Irenand announced a partnership between the two companiesExpediareported, affirmed its FY26 revenue guidance, and announced a new $5B stock buyback authorizationAkamaireportedand provided its outlook for Q2 and FY26Blockprovided areport for Q1President Trump has signed off on a plan to fire Food and Drug Administration Commissioner Marty Makary,2. WALL STREET CALLS:BofAHubSpotto Underperform, while Citi, William Blair and Cantor Fitzgerald also downgraded HubSpot to Neutral-equivalent ratings after the company's Q1 results and commentaryDaiwaQualcommto OutperformWells FargoNiketo Equal WeightMorgan Stanley, TD Cowen and BofAPlanet Fitnessto Neutral-equivalent ratingsCraig-HallumAkamaito Buy3. AROUND THE WEB:PG&Ereleased an inquiry saying it was aware of damage at the Mission substation responsible for a December blackout in San Francisco but left the damaged equipment in place, SF Standard reportsAnthropic reached a cloud computing deal with Akamai, Bloomberg saysMeanwhile, Anthropic is weighing a deal for a nearly $1T valuation, FT reportsMeta'sAI push is causing anger and anxiety among the company's employees, NY Times reportsThe U.S. suspects Nvidiachips were smuggled tot Alibabavia Thailand, Bloomberg reports4. MOVERS:Monster Beverageadvanced after reportingArlo Technologiesrose afterand reiterating its FY26 outlookRocket Lab USAgained after providing anCloudflarefell after providing areport but also announcing 1,100 layoffsCoreWeavedeclined after reporting5. EARNINGS/GUIDANCE:Toyotareported a year-over-yearYelpand reiterated its FY26 revenue outlookGrouponreportedCoinbasereported a sharp drop inWendy'sreportedINDEXES:The Dow rose 12.19, or 0.025%, to 49,609.16, the Nasdaq gained 440.88, or 1.71%, to 26,247.08, and the S&P 500 advanced 61.82, or 0.84%, to 7,398.93.

President Trump has signed off on a plan to fire Food and Drug Administration Commissioner Marty Makary, following a tumultuous period for the regulator that included clashes over vaping, abortion and drug policy, The Wall Street Journal's Liz Essley Whyte reports, citing people familiar with the matter. Makary is seen by other top administration leaders as struggling to manage his agency, sparring frequently with health department officials and at times the White House, the author notes. Biotech stocks that could be impacted by the news include Moderna (MRNA), Sarepta (SRPT), Xencor (XNCR), PTC Therapeutics (PTCT), Biohaven (BHVN), Edgewise Therapeutics (EWTX), Design Therapeutics (DSGN), Ultragenyx (RARE), Avidity Biosciences (RNA), Dyne Therapeutics (DYN), Wave Life Sciences (WVE), MeiraGTx (MGTX), uniQure (QURE), Regenxbio (RGNX), Novavax (NVAX) and Lexeo Therapeutics (LXEO).

The major averages closed broadly higher as oil pulled back, though the ceasefire between the U.S. and Iran continues to be fragile. However, U.S. Defense Secretary Pete Hegseth said the ceasefire "certainly holds" and claimed that two U.S. commercial ships have already "safely transited the strait, showing the lane is clear."Meanwhile, earnings remain strong and AI capital expenditures continue to act as a structural tailwind. There is persistent capital flow into semis and hyperscalers, with expectations for massive multi-year spend cycles anchoring estimates higher.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Palantirprovided areport for Q1PayPalreportedand provided its outlook for Q2 and FY26Coinbaseannounced plans to, or 700 employeesPfizerreportedand reiterated its FY26 guidancePinterestreportedand provided Q2 revenue guidance2. WALL STREET CALLS:Ulta Beautyto Buy at BofA on improved earnings flywheelRobloxto Neutral at Piper Sandler on lack of visibilityArgusChipotleto Buy, expects comp growth to accelerateStephensRepay Holdings, sees "two binary outcomes"Tractor Supplyto Neutral at Piper Sandler3. AROUND THE WEB:FDA officials have blocked publication of several studies supporting the safety of widely used vaccines against Covid-19 and shingles in recent months, NY Times reportsHondaplans to shelve its $11B Canada EV plant as demand sputters, Nikkei reportsNissanis planning to cut roughly 10% of its European workforce and consolidate production lines at its Sunderland Plant as part of a broader restructuring effort, while exploring partnerships such as with Chery to utilize excess capacity and improve financial performance, FT saysBerkshirehas selected Gen Re chairman Charlie Shamieh to succeed Ajit Jain, Vice Chairman of Insurance Operations, when Jain decides to retire, Bloomberg reportsAppleis planning to release a new "Create a Pass' feature for its next iPhone software update, which will allow users to build and customize their digital tickets and gift cards in the Wallet app, Bloomberg says4. MOVERS:Backblazehigher afterand raising its guidance for FY26EverQuote, Digital Oceanand BRC Inc.increase afterDigi Power Xgains after signing aGeneDxlower afterand lowered its guidance for FY26BellRing Brandsand Adtranfalls after5. EARNINGS/GUIDANCE:Portillo's, with EPS and revenue missing consensusIPG Photonicsand provided guidance for Q2, with CEO Mark Gitin commenting, "I am pleased to share that first-quarter revenue came in above our expectations"Neuroneticsand backed its guidance for FY26Surgery Partnersand backed its guidance for FY26, with CEO Eric Evans commenting, "We are encouraged by our solid start to 2026"Expeditors, with EPS and revenue beating consensusINDEXES:The Dow rose 356.35, or 0.73%, to 49,298.25, the Nasdaq gained 258.33, or 1.03%, to 25,326.13, and the S&P 500 advanced 58.47, or 0.81%, to 7,259.22.

Officials at the Food and Drug Administration have blocked publication of several studies supporting the safety of widely used vaccines against Covid-19 and shingles in recent months, according to The New York Times' Christina Jewett, who reports this was confirmed by a spokesman for the Department of Health and Human Services. Publicly traded companies that make vaccines and drugs include Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX), Novavax (NVAX), AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY), and Sanofi (SNY).